Land: Armenía
Tungumál: enska
Heimild: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clobetasol (clobetasol propionate)
Arpimed LLC
D07AD01
clobetasol (clobetasol propionate)
0,5mg/g
cream for topical use
15g aluminium tube
Prescription
Registered
2023-11-07
SUMMARY PRODUCT CHARACTERISTIC (SPC) CLOBETASOL 0.05% CREAM FOR EXTERNAL USE 1. NAME OF THE MEDICINAL PRODUCT – CLOBETASOL 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of Clobetasol 0.05% cream contains: _ACTIVE INGREDIENT:_ clobetasol propionate – 0.5 mg; _For a full list of excipients, see section 6.1 _ 3. PHARMACEUTICAL FORM Cream. White odorless cream. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. These include the following: - Psoriasis (excluding widespread plaque psoriasis) - Recalcitrant dermatoses - Lichen planus - Discoid lupus erythematosus - Other skin conditions which do not respond satisfactorily to less potent steroids. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Clobetasol propionate belongs to the most potent class of topical corticosteroids (Group IV) and prolonged use may result in serious undesirable effects (see section 4.4). If treatment with a local corticosteroid is clinically justified beyond 4 weeks, a less potent corticosteroid preparation should be considered. Repeated but short courses of clobetasol propionate may be used to control exacerbations (see details below). Route of administration: Cutaneous Creams are especially appropriate for moist or weeping surfaces. _ADULTS, ELDERLY AND CHILDREN OVER 1 YEAR _ Apply thinly and gently rub in using only enough to cover the entire affected area once or twice a day until improvement occurs (in the more responsive conditions this may be within a few days), then reduce the frequency of application or change the treatment to a less potent preparation. Allow adequate time for absorption after each application before applying an emollient. Repeated short courses of clobetasol propionate may be used to control exacerbations. In more resistant lesions, especi Lestu allt skjalið